Mohtasib directs PIMS to provide free medicines to patients

Staff Reporter


Federal Ombudsman M. Salman Faruqui, in a bid to facilitate patients at Pakistan Institute of Medical Sciences, has directed the country’s largest hospital’s administration to ensure provision of free of cost medicines to patients from March 24.
He said this while chairing a high-level meeting to review the implementation of recommendations of Ombudsman’s Committee on PIMS reforms.
The Mohtasib expressed the hope that if the recommendations are implemented in true letter and spirit the institute would become a role model for the whole country.
The recommendations are vital to bring reforms in the functioning of PIMS which needed to be implemented as these recommendations are prepared after hard work by the committee members, Faruqui said.
Salman Faruqui directed the PIMS administration that provision of free of cost medicines to patients was an important issue which should be resolved and gave a deadline of March 24 for this purpose.
Briefing the meeting, Hafiz Ahsaan Ahmed Khokhar, Senior Advisor Wafaqi Mohtasib said that the committee gave 50 suggestions for the betterment of the hospital which should be implemented as soon as possible.
He apprised the meeting that currently 901 vacancies were lying vacant in the hospital and suggested that if these posts are filled properly most of the issues could be resolved. The Ombudsman directed the PIMS administration to fill these posts at the earliest.
While briefing the meeting, Dr. Fiaz Ranjha, Health Advisor of Wafaqi Mohtasib gave a detailed look into the matters of PIMS and said that there are 19 such issues which could be resolved without spending a single penny which included security arrangements, biometric system, betterment in Emergency Services and cleanliness problems, etc.
He was of the view that with the implementation of the recommendations, people’s trust could be built on the hospital and it can earn better reputation. PThe meeting was attended by senior advisors of Wafaqi Mohtasib and PIMS top administration.

Share this post

    scroll to top